TG Therapeutics Reports Global Collaboration with Checkpoint Therapeutics for Development, Commercialization of Novel Immuno-Oncology Targeted Antibodies
March 04, 2015 at 08:34 AM EST
TG Therapeutics, Inc. (Nasdaq: TGTX), announced today an agreement with Checkpoint Therapeutics, Inc., a newly formed subsidiary of ...